MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Utah Medical Products General and Administrative Expenses 2011-2026 | UTMD
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Utah Medical Products
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 M | 10.4 M | 10.1 M | 9.8 M | 9.61 M | 5.45 M | 5.39 M | 5.36 M | 5.85 M | 6.11 M | 6.16 M | 6.84 M | 7.22 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11 M | 5.36 M | 7.64 M |
Quarterly General and Administrative Expenses Utah Medical Products
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.83 M | 2.26 M | 2.23 M | - | 2.29 M | 2.56 M | 2.62 M | - | 3.25 M | 3.18 M | 3.26 M | - | 2.93 M | 2.96 M | 2.89 M | - | 2.85 M | 2.89 M | 2.93 M | - | 2.78 M | 2.86 M | 2.84 M | - | 2.88 M | 2.91 M | 2.56 M | - | 1.78 M | 1.81 M | 1.84 M | - | 1.71 M | 1.74 M | 1.69 M | - | 1.7 M | 1.82 M | 1.8 M | - | 1.97 M | 1.99 M | 2.08 M | - | 2.08 M | 2.17 M | 2.08 M | - | 2.16 M | 2.21 M | 2.27 M | - | 2.38 M | 2.37 M | 2.48 M | - | 2.84 M | 2.88 M | 1.45 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.26 M | 1.45 M | 2.4 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
2.97 B | $ 19.84 | -1.24 % | $ 10.1 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
639 M | $ 151.29 | 0.93 % | $ 3.69 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
8.79 M | $ 9.47 | 8.85 % | $ 191 M | USA |
 |
Alcon
ALC
|
251 M | $ 79.26 | -2.12 % | $ 40.4 B |  Schweiz |
 |
InfuSystem Holdings
INFU
|
46.1 M | $ 8.16 | -1.21 % | $ 168 M | USA |
 |
AtriCure
ATRC
|
291 M | $ 37.18 | 0.68 % | $ 1.75 B | USA |
 |
electroCore
ECOR
|
27.2 M | $ 6.87 | 3.15 % | $ 37.9 K | USA |
 |
Haemonetics Corporation
HAE
|
437 M | $ 65.53 | -1.7 % | $ 3.3 B | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 10.47 | 1.01 % | $ 428 M | USA |
 |
Merit Medical Systems
MMSI
|
400 M | $ 81.43 | 0.42 % | $ 4.74 B | USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 80.43 | -1.17 % | $ 16 B | USA |
 |
Harvard Bioscience
HBIO
|
22.8 M | $ 0.51 | 0.98 % | $ 21.6 M | USA |
 |
Glaukos Corporation
GKOS
|
224 M | $ 118.49 | -0.79 % | $ 5.74 B | USA |
 |
OraSure Technologies
OSUR
|
46.2 M | $ 2.95 | 5.56 % | $ 220 M | USA |
 |
Isoray
ISR
|
26.6 M | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 5.74 | 6.49 % | $ 262 M | USA |
 |
iRhythm Technologies
IRTC
|
419 M | $ 157.37 | 1.85 % | $ 4.91 B | USA |
 |
LeMaitre Vascular
LMAT
|
36.3 M | $ 86.08 | 1.31 % | $ 1.93 B | USA |
 |
Pulse Biosciences
PLSE
|
15.8 M | $ 13.62 | -1.52 % | $ 654 M | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 137.44 | 0.08 % | $ 7.33 B | USA |
 |
Intuitive Surgical
ISRG
|
2.14 B | $ 497.56 | -1.32 % | $ 177 B | USA |
 |
STERIS plc
STE
|
1.33 B | $ 263.8 | 0.4 % | $ 26 B | USA |
 |
Microbot Medical
MBOT
|
4.13 M | $ 1.83 | 1.39 % | $ 18.7 M |  Israel |
 |
Nephros
NEPH
|
8.91 M | $ 4.63 | 7.42 % | $ 48.1 M | USA |
 |
Milestone Scientific
MLSS
|
12.3 M | $ 0.27 | -4.98 % | $ 21.5 M | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 23.19 | -1.15 % | $ 3.99 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.6 B | $ 12.28 | -1.56 % | $ 2.5 B | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 40.12 | 2.27 % | $ 132 M | USA |
 |
Predictive Oncology
POAI
|
7.42 M | - | - | $ 31.1 M | USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 201.89 | -0.82 % | $ 58.1 B | USA |
 |
Repligen Corporation
RGEN
|
219 M | $ 151.0 | 1.09 % | $ 8.41 M | USA |
 |
ResMed
RMD
|
739 M | $ 251.72 | -2.55 % | $ 36.8 B | USA |
 |
BioLife Solutions
BLFS
|
40.5 M | $ 22.42 | 2.84 % | $ 1.03 B | USA |
 |
Stereotaxis
STXS
|
14 M | $ 2.23 | 1.59 % | $ 180 M | USA |
 |
Retractable Technologies
RVP
|
13.6 M | $ 0.7 | -0.31 % | $ 21 M | USA |
 |
STAAR Surgical Company
STAA
|
89.9 M | $ 18.13 | -4.33 % | $ 891 M | USA |
 |
Teleflex Incorporated
TFX
|
995 M | $ 103.43 | -0.92 % | $ 4.84 B | USA |
 |
West Pharmaceutical Services
WST
|
338 M | $ 233.58 | 1.04 % | $ 17.1 B | USA |